腎症性シスチン症治療の世界市場2019年-2027年

◆英語タイトル:Nephropathic Cystinosis Treatment - Global Market Outlook (2019 -2027)
◆商品コード:SMRC21FB018
◆発行会社(リサーチ会社):Stratistics MRC
◆発行日:2020年11月
◆ページ数:約150 
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥473,100見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Stratistics MRC社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、腎症性シスチン症治療の世界市場を調査対象とし、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、治療別(セラピー)分析、用途別(外来手術センター、クリニック、病院、専門/小売薬局)分析、地域別分析、主要な市場開拓、企業情報などをお届けいたします。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・腎症性シスチン症治療の世界市場規模:治療別(セラピー)
・腎症性シスチン症治療の世界市場規模:用途別(外来手術センター、クリニック、病院、専門/小売薬局)
・腎症性シスチン症治療の世界市場規模:地域別
・主要な市場開拓
・企業情報
【レポートの概要】

According to Stratistics MRC, the Global Nephropathic Cystinosis Treatment Market is accounted for $215.00 million in 2019 and is expected to reach $270.25 million by 2027 growing at a CAGR of 2.9% during the forecast period. Emergence of patient assistance, helping hand programs for nephropathic cystinosis patients and rise in awareness regarding nephropathic cystinosis among people through various programs are the major factors propelling the market growth. However, lack of healthcare professionals is hampering the market growth.

Nephropathic cystinosis is a rare form of disease. It is an inherited (autosomal recessive) lysosomal storage disorder caused by defective transport of the amino acid cystine out of lysosomes. The stored cystine is poorly soluble and crystallizes within the lysosomes of many cell types, leading to widespread tissue and organ damage. Nephropathic cystinosis treatment comprises cysteamine depletion therapy with symptomatic treatment for the disease. At a severe stage, renal transplantation option is adopted.

Based on the treatment type, the therapy segment is going to have a lucrative growth during the forecast period due to the factors such as better efficacy to cure symptoms, delayed renal transplantation, and novel therapy approaches being developed in recent times. The therapy segment is further sub-segmented into systemic depletion therapy and symptomatic therapy. Systemic depletion therapy is a more popular therapy due to being the only effective treatment option for nephropathic cystinosis.

By geography, North America is going to have a lucrative growth during the forecast period due owing to comparatively higher diagnosed patient population for nephropathic cystinosis in the region, availability of U.S. FDA approved products, and research funding for new treatment approaches. For instance, as per Cystinosis Research Network (CRN), cystinosis affects an estimated 2,000 people worldwide with just over 600 of those diagnosed living in the U.S.

Some of the key players profiled in the Nephropathic Cystinosis Treatment Market include AVROBIO, Inc, Chiesi Farmaceutici S.p.A, Eloxx Pharmaceuticals, GlaxoSmithKline plc, Horizon Therapeutics, Leadiant Biosciences, Inc, Mylan, and Recordati Rare Diseases.

Treatment Types Covered:
• Renal Transplantation
• Therapy

Applications Covered:
• Ambulatory Surgical Centres
• Clinics
• Hospitals
• Specialty/Retail Pharmacies

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019 2020, 2024, and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
• Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client’s interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

【レポートの目次】

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Nephropathic Cystinosis Treatment Market, By Treatment Type
5.1 Introduction
5.2 Renal Transplantation
5.3 Therapy
5.3.1 Cysteine Depleting Therapy
5.3.2 Symptomatic Therapy
5.3.3 Systemic Depletion Therapy
6 Global Nephropathic Cystinosis Treatment Market, By Application
6.1 Introduction
6.2 Ambulatory Surgical Centres
6.3 Clinics
6.4 Hospitals
6.5 Specialty/Retail Pharmacies
7 Global Nephropathic Cystinosis Treatment Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 AVROBIO, Inc
9.2 Chiesi Farmaceutici S.p.A
9.3 Eloxx Pharmaceuticals
9.4 GlaxoSmithKline plc
9.5 Horizon Therapeutics
9.6 Leadiant Biosciences, Inc
9.7 Mylan
9.8 Recordati Rare Diseases
List of Tables
1 Global Nephropathic Cystinosis Treatment Market Outlook, By Region (2018-2027) ($MN)
2 Global Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
3 Global Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
4 Global Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
5 Global Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
6 Global Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
7 Global Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
8 Global Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
9 Global Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
10 Global Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
11 Global Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
12 Global Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)
13 North America Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
14 North America Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
15 North America Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
16 North America Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
17 North America Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
18 North America Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
19 North America Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
20 North America Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
21 North America Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
22 North America Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
23 North America Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
24 North America Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)
25 Europe Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
26 Europe Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
27 Europe Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
28 Europe Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
29 Europe Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
30 Europe Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
31 Europe Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
32 Europe Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
33 Europe Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
34 Europe Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
35 Europe Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
36 Europe Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)
37 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
38 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
39 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
40 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
41 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
42 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
43 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
44 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
45 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
46 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
47 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
48 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)
49 South America Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
50 South America Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
51 South America Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
52 South America Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
53 South America Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
54 South America Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
55 South America Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
56 South America Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
57 South America Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
58 South America Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
59 South America Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
60 South America Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)
61 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
62 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
63 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
64 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
65 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
66 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
67 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
68 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
69 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
70 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
71 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
72 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[腎症性シスチン症治療の世界市場2019年-2027年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆